Specialty Chemicals company Camlin Fine Sciences announced Q3FY26 results Financial Highlights: Revenue from operations: Rs 4,572 million against Rs 4,310.2 million during Q3FY25, change 6%. EBITDA: Rs 220.3 million against Rs 577.6 million during Q3FY25, change -62%. EBITDA Margin: 4.8% for Q3FY26. PBT: Rs -278.5 million against Rs 87 million during Q3FY25. PAT: Rs -279 million against Rs 15.5 million during Q3FY25. Business Highlights: Pricing pressure on Straights impacted the profitability Blends business maintains steady growth across key markets. CFS acquired a controlling stake in Vinpai on 30th November and contributed Rs 129 million in revenue in Q3FY26 Vanillin business was impacted by tariff-related challenges. Benefits of higher realization on the internal channel inventory of Vanillin in subsequent quarters due to the withdrawal of the tariff. Employee costs and other expenses remain under control, but increase due to the acquisition of Vinpai during the quarter EBITDA for the quarter was Rs. 307 mn, with a margin of 6.7%. Fire incident was reported at one unit in Brazil on February 7, 2026; loss assessment by the insurer is in progress, and operations at the unit are suspended. However, other unit continues to operate, alternative arrangements being made to service the customers, the quantum of loss not determinable at this stage. CFS Europe is likely to be liquidated. Losses of discontinued operations would be curtailed Outlook for the remaining financial year: Vanillin business expects to improve on realisations as well as volume with the withdrawal of the US tariff. Blends are likely to maintain growth momentum in all geographies despite challenges in CFS Brazil. Result PDF
Specialty Chemicals company Camlin Fine Sciences announced Q1FY26 results Revenue: Rs 4,236 million compared to Rs Rs 3,809 million during Q1FY25. EBITDA: Rs 190 million compared to Rs Rs 392 million during Q1FY25. EBITDA Margin: 4.49% for Q1FY26. PAT: Rs -43 million compared to Rs Rs -182 million during Q1FY25. Result PDF